NL7005168A - - Google Patents

Info

Publication number
NL7005168A
NL7005168A NL7005168A NL7005168A NL7005168A NL 7005168 A NL7005168 A NL 7005168A NL 7005168 A NL7005168 A NL 7005168A NL 7005168 A NL7005168 A NL 7005168A NL 7005168 A NL7005168 A NL 7005168A
Authority
NL
Netherlands
Application number
NL7005168A
Other versions
NL176269C (nl
NL176269B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH589569A external-priority patent/CH512490A/de
Application filed filed Critical
Publication of NL7005168A publication Critical patent/NL7005168A/xx
Publication of NL176269B publication Critical patent/NL176269B/xx
Application granted granted Critical
Publication of NL176269C publication Critical patent/NL176269C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NLAANVRAGE7005168,A 1969-04-18 1970-04-10 Werkwijze voor het bereiden van een lysergzuuramidederivaat. NL176269C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH589569A CH512490A (de) 1969-04-18 1969-04-18 Verfahren zur Herstellung von heterocyclischen Verbindungen
CH1326269 1969-09-02

Publications (3)

Publication Number Publication Date
NL7005168A true NL7005168A (https=) 1970-10-20
NL176269B NL176269B (nl) 1984-10-16
NL176269C NL176269C (nl) 1985-03-18

Family

ID=25698602

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7005168,A NL176269C (nl) 1969-04-18 1970-04-10 Werkwijze voor het bereiden van een lysergzuuramidederivaat.

Country Status (9)

Country Link
US (1) US3755328A (https=)
JP (1) JPS5416520B1 (https=)
BE (1) BE749072A (https=)
DE (1) DE2017560C2 (https=)
DK (1) DK140373C (https=)
FR (1) FR2043444A5 (https=)
GB (1) GB1298277A (https=)
NL (1) NL176269C (https=)
SE (1) SE361173B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH587858A5 (https=) * 1973-11-28 1977-05-13 Sandoz Ag
US4138565A (en) * 1975-05-31 1979-02-06 Sandoz Ltd. Stable solutions and processes for their preparation
CH619468A5 (https=) * 1976-01-12 1980-09-30 Sandoz Ag
YU40004B (en) * 1977-07-21 1985-06-30 Lek Tovarna Farmacevtskih Praocess for preparing n-substituted esters of 9,10-dihydrlysergic acid
YU216177A (en) * 1977-09-09 1984-02-29 Rudolf Rucman Process for preparing 2-bromo ergosine
YU41110B (en) * 1978-07-19 1986-12-31 Lek Tovarna Farmacevtskih Process for preparing dextrorotatory ergot alcaloids acid addition salts
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
US5006526A (en) * 1988-10-17 1991-04-09 Louisiana State University Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis
IN2012DN04858A (https=) * 2009-12-23 2015-09-25 Map Pharmaceuticals Inc
KR20140042868A (ko) 2011-06-23 2014-04-07 맵 파마슈티컬스, 인코포레이티드 신규한 플루오로에르골린 유사체
SG10201509139QA (en) 2011-12-19 2015-12-30 Map Pharmaceuticals Inc Novel iso-ergoline derivatives
CA2859175A1 (en) 2011-12-21 2013-06-27 Map Pharmaceuticals, Inc. Novel neuromodulatory compounds
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH395119A (de) * 1961-05-10 1965-07-15 Sandoz Ag Verfahren zur Herstellung von heterocyclischen Verbindungen
CH469735A (de) * 1965-11-02 1969-03-15 Sandoz Ag Verfahren zur Herstellung heterocyclischer Verbindungen
CH508628A (de) * 1968-06-25 1971-06-15 Sandoz Ag Verfahren zur Herstellung neuer heterocyclischer Verbindungen

Also Published As

Publication number Publication date
DE2017560C2 (de) 1983-11-24
DK140373C (da) 1980-01-07
DE2017560A1 (de) 1970-11-05
GB1298277A (en) 1972-11-29
DK140373B (da) 1979-08-13
US3755328A (en) 1973-08-28
FR2043444A5 (https=) 1971-02-12
NL176269C (nl) 1985-03-18
BE749072A (fr) 1970-10-16
NL176269B (nl) 1984-10-16
JPS5416520B1 (https=) 1979-06-22
SE361173B (https=) 1973-10-22

Similar Documents

Publication Publication Date Title
AU465413B2 (https=)
FR2043444A5 (https=)
AU450150B2 (https=)
AU442375B2 (https=)
AU2355770A (https=)
AU470301B1 (https=)
AU5113869A (https=)
CS150906B2 (https=)
AU442357B2 (https=)
AU442554B2 (https=)
AU442463B2 (https=)
AU442285B2 (https=)
AU442535B2 (https=)
AU470661B1 (https=)
AU442322B2 (https=)
AU442538B2 (https=)
AU438128B2 (https=)
AU410358B2 (https=)
AU5109569A (https=)
AU5598769A (https=)
AU4949169A (https=)
AU5228269A (https=)
AU5077469A (https=)
BE732828A (https=)
BE734706A (https=)

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
V4 Discontinued because of reaching the maximum lifetime of a patent